Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00920462
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
|---|---|---|---|---|---|
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
421 | 6-CARBAMIMIDOYL-4-(3-HYDROXY-2- METHYL-BENZOYLAMINO)-NAPHTHALENE- 2-CARBOXYLIC ACID METHYL ESTER | A | 1ZSK | 0.72 |  |
570 | 2-(2-BENZOYL-PHENYLAMINO)-3-{4- [2-(5-METHYL-2-PHENYL-OXAZOL-4- YL)-ETHOXY]-PHENYL}-PROPIONIC ACID | A,D | 1RDT | 0.71 | |
| 570 | 2-(2-BENZOYL-PHENYLAMINO)-3-{4- [2-(5-METHYL-2-PHENYL-OXAZOL-4- YL)-ETHOXY]-PHENYL}-PROPIONIC ACID | A,D | 1FM9 | 0.71 | |
2GG | 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)- N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE- 3-CARBOXAMIDE | A | 2UWD | 0.71 | |
3IH | N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL- L-VALYL-N~1~-((1R,2Z)-4-(BENZYLOXY)- 4-OXO-1-{[(3R)-2-OXOPYRROLIDIN- 3-YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE | A | 2HOB | 0.87 | |
| 3IH | N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL- L-VALYL-N~1~-((1R,2Z)-4-(BENZYLOXY)- 4-OXO-1-{[(3R)-2-OXOPYRROLIDIN- 3-YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE | A,B | 2AMQ | 0.87 | |
| 3IH | N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL- L-VALYL-N~1~-((1R,2Z)-4-(BENZYLOXY)- 4-OXO-1-{[(3R)-2-OXOPYRROLIDIN- 3-YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE | A,B,C,D | 3D23 | 0.87 | |
| 3IH | N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL- L-VALYL-N~1~-((1R,2Z)-4-(BENZYLOXY)- 4-OXO-1-{[(3R)-2-OXOPYRROLIDIN- 3-YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE | A,B | 2Q6F | 0.87 | |
I12 | N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]- L-ALANYL-L-VALYL-N~1~-((1S)-4-ETHOXY- 4-OXO-1-{[(3S)-2-OXOPYRROLIDIN- 3-YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE | A,B | 1WOF | 0.75 | |
| I12 | N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]- L-ALANYL-L-VALYL-N~1~-((1S)-4-ETHOXY- 4-OXO-1-{[(3S)-2-OXOPYRROLIDIN- 3-YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE | A,B | 2AMP | 0.75 | |
SOY | OXACILLIN-ACYLATED SERINE | A | 2IWD | 0.71 | |
W8R | 5-(7-(5-HYDRO-4-METHYL-2-OXAZOLYL)PHENOXY)HEPTYL)- 3-METHYL ISOXAZOLE | 1 | 2RR1 | 0.7 | |
GW4 | N-[(2S)-2-[(2-BENZOYLPHENYL)AMINO]- 3-{4-[2-(5-METHYL-2-PHENYL-1,3- OXAZOL-4-YL)ETHOXY]PHENYL}PROPYL]ACETAMIDE | A,B | 2POB | 0.72 | |
4DE | 1-(4-METHOXYPHENYL)-3,5-DIMETHYL- 1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER | A,B | 1Y2D | 0.71 | |
W84 | 5-(7-(5-HYDRO-4-METHYL-2-OXAZOLYL)PHENOXY)HEPTYL)- 3-METHYL ISOXAZOLE | 1 | 2RS1 | 0.7 | |
| W84 | 5-(7-(5-HYDRO-4-METHYL-2-OXAZOLYL)PHENOXY)HEPTYL)- 3-METHYL ISOXAZOLE | 1 | 1RUD | 0.7 | |
| W84 | 5-(7-(5-HYDRO-4-METHYL-2-OXAZOLYL)PHENOXY)HEPTYL)- 3-METHYL ISOXAZOLE | 1 | 1RUI | 0.7 | |
| W84 | 5-(7-(5-HYDRO-4-METHYL-2-OXAZOLYL)PHENOXY)HEPTYL)- 3-METHYL ISOXAZOLE | 1 | 1RUH | 0.7 | |
W71 | 5-(7-(4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)HEPTYL)- 3-METHYL ISOXAZOLE | 1,4 | 1PIV | 0.71 | |
| W71 | 5-(7-(4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)HEPTYL)- 3-METHYL ISOXAZOLE | 1,4 | 1D4M | 0.71 | |
| W71 | 5-(7-(4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)HEPTYL)- 3-METHYL ISOXAZOLE | 1 | 2R04 | 0.71 | |
541 | (2R)-N-HYDROXY-2-[(3S)-3-METHYL- 3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}- 2-OXOPYRROLIDIN-1-YL]PROPANAMIDE | A,B | 2FV5 | 0.7 | |
W03 | 2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]- PROPANYL)-4-[2-METHYL-4-ISOXAZOLYL]- PHENOL | 1,4 | 1QJY | 0.7 | |
W35 | 5-(5-(4-(4,5-DIHYDRO-2-OXAZOLY)PHENOXY)PENTYL)- 3-METHYL ISOXAZOLE | 1 | 1RUE | 0.7 | |
| W35 | 5-(5-(4-(4,5-DIHYDRO-2-OXAZOLY)PHENOXY)PENTYL)- 3-METHYL ISOXAZOLE | 1 | 2R06 | 0.7 | |
| W35 | 5-(5-(4-(4,5-DIHYDRO-2-OXAZOLY)PHENOXY)PENTYL)- 3-METHYL ISOXAZOLE | 1 | 1RUC | 0.7 | |
| W35 | 5-(5-(4-(4,5-DIHYDRO-2-OXAZOLY)PHENOXY)PENTYL)- 3-METHYL ISOXAZOLE | 1 | 1RUG | 0.7 | |
PXB | parecoxib | A | 2ZMB | 0.72 | |
REW | (2S,3S)-1-(4-METHOXYPHENYL)-3-(3- (2-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHOXY)BENZYL)- 4-OXOAZETIDINE-2-CARBOXYLIC ACID | A | 2REW | 0.7 | |
4PR | (3S)-1-{[(3,5-DIMETHYLISOXAZOL- 4-YL)AMINO]CARBONYL}-4,4-DIMETHYLPYRROLIDIN- 3-YL{(1S)-1-[1-HYDROXY-2-OXO-2- {[(1R)-1-PHENYLETHYL]AMINO}ETHYL]PENTYL}CARBAMATE | A | 2BDL | 0.71 | |
6C3 | 6-CHLORO-3-(3-METHYLISOXAZOL-5- YL)-4-PHENYLQUINOLIN-2(1H)-ONE | A | 2I0V | 0.73 | |
AG7 | 4-{2-(4-FLUORO-BENZYL)-6-METHYL- 5-[(5-METHYL-ISOXAZOLE-3-CARBONYL)- AMINO]-4-OXO-HEPTANOYLAMINO}-5- (2-OXO-PYRROLIDIN-3-YL)-PENTANOIC ACID ETHYL ESTER | A | 1CQQ | 0.84 | |
4BO | (3S)-3-amino-4-oxo-4-[(4-phenylmethoxyphenyl)amino]butanoic acid | A | 3CHP | 0.7 | |
550 | methyl (1R,2S)-2-(hydroxycarbamoyl)- 1-{4-[(2-methylquinolin-4-yl)methoxy]benzyl}cyclopropanecarboxylate | A,B | 3EDZ | 0.7 | |
D27 | 2-{[(2E)-3-(3,4-dimethoxyphenyl)prop- 2-enoyl]amino}benzoic acid | A,B,C,D | 2VD0 | 0.73 | |
W59 | 5-(7-(5-HYDRO-4-ETHYL-2-OXAZOLYL)PHENOXY)HEPTYL)- 3-METHYL ISOXAZOLE | 1 | 2RS3 | 0.7 | |
2GJ | 5-[2,4-DIHYDROXY-5-(1-METHYLETHYL)PHENYL]- N-ETHYL-4-[4-(MORPHOLIN-4-YLMETHYL)PHENYL]ISOXAZOLE- 3-CARBOXAMIDE | A | 2VCI | 0.73 | |
234 | 5-{2-FLUORO-5-[3-(3-HYDROXY-2-METHOXYCARBONYL- PHENOXY)-PROPENYL]-PHENYL}-ISOXAZOLE- 3-CARBOXYLIC ACID | A | 1Q1M | 0.71 | |
19B | 4-methyl-N-(3-morpholin-4-ylphenyl)- 3-(3-piperidin-4-yl-1,2-benzisoxazol- 6-yl)benzamide | A | 3E93 | 0.73 | |
CY6 | N-((3S,6R)-6-((S,E)-4-ETHOXYCARBONYL- 1-((S)-2-OXOPYRROLIDIN-3-YL)BUT- 3-EN-2-YLCARBAMOYL)-2,9-DIMETHYL- 4-OXODEC-8-EN-3-YL)-5-METHYLISOXAZOLE- 3-CARBOXAMIDE | A | 2ALV | 0.76 | |
R2C | 5-METHOXY-2-[(4-PHENOXYPHENYL)AMINO]BENZOIC ACID | A | 2PRL | 0.71 | |
XIN | methyl (3Z)-3-{[(4-{methyl[(4-methylpiperazin- 1-yl)acetyl]amino}phenyl)amino](phenyl)methylidene}- 2-oxo-2,3-dihydro-1H-indole-6-carboxylate | A | 3C7Q | 0.71 | |